Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer - Lara, Pedro C. (Centro Oncológico Integral de Canarias. Hospital Universitario San Roque. Universidad Fernando Pessoa Canarias) ; Rodríguez-Melcón, Juan I. (Hospital Universitario de Gran Canaria Dr. Negrín) ; Palacios-Eito, Amalia (Hospital Universitario "Reina Sofía" (Còrdova). Instituto Maimónides de Investigación Biomédica de Córdoba. Oncología Radioterápica) ; Lozano, Antonio (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ; Hervás-Morón, Asunción (Hospital Universitario Ramón y Cajal (Madrid)) ; Villafranca, Elena (Hospital Universitario de Navarra. Oncología Radioterápica) ; Gómez-Iturriaga, Alfonso (Hospital Universitario de Cruces (Barakaldo, País Basc)) ; Sancho-Pardo, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; Maldonado, Xavier (Vall d'Hebron Institut d'Oncologia)
 
Comments (0) | Reviews (0)
Start a discussion about any aspect of this document.

 Subscribe to this discussion. You will then receive all new comments by email.

Add comment


Once logged in, authorized users can also attach files.
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.
          You can use some HTML tags: <a href>, <strong>, <blockquote>, <br />, <p>, <em>, <ul>, <li>, <b>, <i>